NEW, NOVEL LIPID-LOWERING AGENTS FOR REDUCING CARDIOVASCULAR RISK: BEYOND STATINS

Descargar Publicación
Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease Plants Secondary Metabolites as Blood Glucose-Lowering Molecules